Nextera AS Alternatives & Competitors
12 companies similar to Nextera AS — Opening a new arena for drug discovery
Companies similar to Nextera AS
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
OSE Immunotherapeutics
Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
Rival Readout
Competing with Nextera AS? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Evommune
Developing innovative therapies that target key drivers of chronic inflammatory diseases.
Sentien Biotechnologies, Inc.
Restoring Balance to the Immune System
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
Eugit Therapeutics
Tissue targeting of therapies
Chance Pharmaceuticals 畅溪制药
A clinical-stage biotech company focusing on discovering, developing and commercializing i...
Attovia Therapeutics
Creating medicines for immune-mediated disease using ATTOBODY®, a proprietary biologics pl...
InflaRx
Controlling Inflammation - developing drugs to treat life threatening and chronic inflamma...
About Nextera AS
Nextera AS is a biotechnology startup based in Norway founded in 2009. The company's slogan, "Opening a new arena for drug discovery," reflects its mission to revolutionize therapeutic intervention in autoimmunity, chronic inflammatory disorders, and cancer. Nextera's distinctive approach involves modulating diseases a...
Drug Discovery, Therapeutic Intervention, Autoimmunity, Chronic Inflammatory Disorders, Cancer Treatment, Target Discovery, New Targets, Cognate Drugs, Complex Diseases, Therapies Development, Immune System Modulation, Clinical Material Analysis, Diseased Tissue Focus, Immune Cascade, Patient-centered Approach
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Nextera AS: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Nextera AS on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.